학술논문
43024 Bimekizumab improves joint measures in patients with active psoriatic arthritis and moderate or severe psoriasis: Pooled 16-week results from phase 3 randomized, placebo-controlled studies BE OPTIMAL and BE COMPLETE
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology September 2023 89(3) Supplement:AB128-AB128
Subject
Language
ISSN
0190-9622